Document Detail


Peritoneal dialysis patients with high effluent fibrin degradation products.
MedLine Citation:
PMID:  19886315     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Encapsulating peritoneal sclerosis (EPS) is a major and fatal complication of peritoneal dialysis (PD). For treatment, the efficacies of steroids, tamoxifen, immunosuppressants, and surgical total intestinal enterolysis have been reported, but the results have not been sufficient. Because treatment after the onset of EPS is limited, a prophylactic therapy is needed. We previously reported that the level of effluent fibrin degradation products (eFDPs) is predictive of EPS. In the present study, we investigated the clinical course of PD cases with high eFDP levels, and the effect of prophylactic steroid therapy against EPS. Between January 2002 and August 2008, we investigated 310 PD patients, of whom 22 had an eFDP level of 30 microg/mL or more in 4-hour effluent from a fast peritoneal equilibration test (PET). Mean patient age was 62.6 +/- 11.1 years, and mean duration of dialysis was 42.7 +/- 45.5 months (range: 1 - 202 months). During a fast PET performed every 6 months, we measured, in 4-hour effluent, eFDPs, cancer antigen 125 (eCA125), and dialysate-to-plasma creatinine (D/P Cr). In addition, we calculated D/P beta2-microglobulin (beta2MG) from levels in overnight dialysis effluent and blood. In the 22 cases, the mean eFDP level was 66.6 +/- 39.2 microg/mL; the D/P Cr 0.78 +/- 0.1; and the D/P beta2MG 0.45 +/- 0.2. Steroid (5 - 30 mg daily) was administered to 8 of the 22 patients. In the 8 treated cases, the eFDP level, the D/P Cr, and the D/P beta2MG declined, but did not return to normal, and EPS developed in 2 patients. The eFDP level was high when dialysis was introduced, but returned to normal in 2 of the remaining 14 patients. In 1 of the 14 cases, peritonitis developed 5 times, followed by rapid elevation in the eFDP level. The patient with this intractable peritonitis was switched to hemodialysis. The other 11 patients received no steroid therapy. In 1 of these 11 patients, the eFDP level declined, but not in the others. We suggest that active steroid therapy for patients with a high level of eFDPs may prevent EPS development.
Authors:
Misaki Moriishi; Hideki Kawanishi; Shinichiro Tsuchiya
Related Documents :
17804675 - Chronic peritoneal dialysis in the united states: declining utilization despite improvi...
6828945 - An interracial study of continuous ambulatory peritoneal dialysis (capd) in natal.
17664875 - Free radical and antioxidant levels in patients with secondary peritonitis and their pr...
2137745 - Computed tomographic peritoneography in the investigation of abdominal wall and genital...
22207115 - Platelet glycoprotein iib/iiia polymorphism hpa-3 b/b is associated with increased risk...
2319265 - Natural history and outcome of psychogenic seizures: a clinical study in 50 patients.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Advances in peritoneal dialysis. Conference on Peritoneal Dialysis     Volume:  25     ISSN:  1197-8554     ISO Abbreviation:  Adv Perit Dial     Publication Date:  2009  
Date Detail:
Created Date:  2009-11-05     Completed Date:  2009-12-15     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9104803     Medline TA:  Adv Perit Dial     Country:  Canada    
Other Details:
Languages:  eng     Pagination:  41-4     Citation Subset:  IM    
Affiliation:
Tsuchiya General Hospital, Hiroshima, Japan. usagi@tsuchiya-hp.jp
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Biological Markers / analysis
Creatinine / metabolism
Fibrin Fibrinogen Degradation Products / metabolism*
Humans
Middle Aged
Peritoneal Dialysis / adverse effects*
Peritoneal Fibrosis / diagnosis*,  drug therapy,  etiology,  prevention & control
Peritoneum / metabolism
Steroids / therapeutic use
beta 2-Microglobulin / metabolism
Chemical
Reg. No./Substance:
0/Biological Markers; 0/Fibrin Fibrinogen Degradation Products; 0/Steroids; 0/beta 2-Microglobulin; 60-27-5/Creatinine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The relationship between peritoneal leukocyte count, fluid cultures, and clinical results in periton...
Next Document:  A case of encapsulating peritoneal sclerosis suspected to result from the use of icodextrin peritone...